Welcome medical professionals! Have you ever encountered a case of Aplasia Cutis Congenita (ACC) in your practice? This rare disorder can be quite perplexing and challenging to diagnose. But fear not, because in this blog post, we will dive deep into understanding the causes, symptoms and treatment options for ACC. So sit tight, grab a cup of coffee and let's unravel this mystery together!
Aplasia cutis congenita (ACC) is a rare birth defect characterized by the absence of skin on one or more areas of the body. ACC can occur anywhere on the body, but is most commonly found on the scalp. The affected area may be small, measuring only a few millimeters in diameter, or may be large, involving a significant portion of the scalp. There are two types of ACC: localized and generalized. Localized ACC affects only a single area of the body, while generalized ACC involves multiple areas. Generalized ACC is further divided into two subtypes: total and segmental. Total generalized ACC is characterized by complete absence of skin over the entire body, while segmental generalized ACC involves multiple areas of skin loss that are not connected to one another. The cause of ACC is unknown in most cases. However, some cases have been linked to genetic mutations or chromosomal abnormalities. Additionally, exposure to certain environmental factors during pregnancy has been associated with an increased risk for developing ACC. These include certain infections (e.g., cytomegalovirus), medications (e.g., retinoids), and chemicals (e.g., mercury). ACC can be diagnosed based on clinical features and confirmed with histological examination of the affected skin. Treatment typically involves wound care and protection from infection until the skin heals spontaneously or regenerates through surgical methods. In some cases, treatment may also involve administration of topical steroids or other medications to promote healing.
Aplasia cutis congenita (ACC) is a rare birth defect characterized by the absence of skin on one or more areas of the body. The cause of ACC is unknown, but it is thought to be caused by a disruption in the development of the embryonic epidermis. This disruption can occur during any stage of development, from early embryogenesis to late fetal development. The most common symptom of ACC is a localized area of hairless, smooth skin. This area may be small, like a dime-sized spot on the scalp, or large, like an entire limb. Other symptoms include: Dystrophic nails (nails that are thickened, brittle, and curved), Hypotrichosis (abnormal hair growth), Hyperhidrosis (excessive sweating), Atrophic scarring (thin, pitted scars).
There are a variety of treatment options available for aplasia cutis congenita, depending on the severity of the condition. For milder cases, treatment may simply involve keeping the affected area clean and dry to prevent infection. More severe cases may require surgery to close the open wound. In some cases, skin grafts may be necessary. For babies born with aplasia cutis congenita, it is important to monitor them closely for any signs of infection. If an infection does occur, it is important to treat it promptly to avoid serious complications.
In summary, Aplasia Cutis Congenita is a rare skin disorder that can be caused by multiple factors. It is important for medical professionals to understand the possible causes, symptoms and treatment options associated with this condition in order to provide patients with the best possible care. As research into ACC continues, more effective treatments may become available for individuals affected by this disorder.
1.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
2.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
3.
Recurrent UTIs impact eGFR in children with vesicoureteral reflux
4.
Month-Long Wait Times Caused by US Physician Shortage.
5.
Pharyngoesophageal junction cancer is not a good candidate for endoscopically assisted transoral surgery.
1.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
2.
The Importance of Early Detection in Angiosarcoma: A Story of Survival
3.
Leukemia in Focus: Tools, Trials, and Therapy Strategies for Modern Medical Practice
4.
New Research Advances in the Treatment of Multiple Myeloma and Plasmacytoma
5.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Incidence of Lung Cancer- An Overview to Understand ALK Rearranged NSCLC
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
4.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion IV
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation